Gerald Lee, MD; Stanley Fineman, MD; Samantha Knox, MD Disclosures

To download the mp3 file, right click on the player and select Save audio as.

Interested in claiming CME for this episode? Click here

Show Notes

Welcome to Season Two of AllergyTalk! In this season, we are going to introduce you to each of the Allergy Watch assistant editors who work so hard on scouring the literature in allergy and immunology and bring you the most interesting articles in every issue! 

Today we are joined by Dr. Samanta Knox, MD from Gunderson Health System in La Crosse, WI. We will review the Jan-Feb 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.  

To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch.  Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles.

Articles Reviewed:

  1. Allergen immunotherapy effectively reduces the risk of exacerbations and lower respiratory tract infections in both seasonal and perennial allergic asthma: a nationwide epidemiological study.
  2. Prospective evaluation of tolerance to unheated milk-boiled egg after baked milk-egg tolerance under 2 years.
  3. Multiscale study of the oral and gut environments in children with high- and low-threshold peanut allergy.

ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.

Speaker Disclosures back to top

Gerald Lee, MD
No relevant financial relationships with ineligible companies to disclose

Stanley Fineman, MD
Research: DBV, Novartis, Alladapt

Samantha Knox, MD
No relevant financial relationships with ineligible companies to disclose